| Theme | Hilar and Intrahepatic Cholangiocarcinoma | |
|---|---|---|
| Title | Surgical Resection for Perihilar Cholangiocarcinoma | |
| Publish Date | 2011/12 | |
| Author | Gen Sugawara | Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
| Author | Tomoki Ebata | Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
| Author | Yukihiro Yokoyama | Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
| Author | Tsuyoshi Igami | Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
| Author | Yu Takahashi | Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
| Author | Masato Nagino | Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine |
| [ Summary ] | Surgical resection is the only curative treatment for patients with perihilar cholangiocarcinoma. Therefore, aggressive surgery to achieve curative resection is a primary therapeutic choice, unless there are factors which would cause the condition to be deemed unresectable. Precise preoperative evaluation of tumor staging is mandatory to plan a rational resectional procedure. It is also important to control biliary infection and liver dysfunction perioperatively, since most patients with perihilar cholangiocarcinoma have obstructive jaundice, cholangitis, and abnormal liver function on admission. In this article, we outline our perioperative management and surgical strategies for perihilar cholangiocarcinoma. |
|